[
    "Safety concerns: The development of a new vaccine may involve the use of new or untested technologies, which could pose safety risks to those who receive the vaccine.",
    "Logistical challenges: The production and distribution of a new vaccine may present logistical challenges, such as the need for specialized facilities, the need for a large workforce, and the need for a complex supply chain.",
    "Financial challenges: The development of a new vaccine may be expensive, and the cost of producing and distributing the vaccine may be prohibitive for some countries or populations.",
    "Political challenges: The development of a new vaccine may be influenced by political considerations, such as the relationship between countries or the influence of pharmaceutical companies on government policies.",
    "Communication challenges: The development of a new vaccine may require effective communication between scientists, policymakers, and the public, in order to build trust and ensure that the vaccine is safe and effective."
]